Condition
Refractive Errors
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownEye Health Intervention Study in Upper ManhattanNCT06112431 · 2027-04-01
WITHDRAWNEffect of Peripapillary Atrophy to Diagnose Glaucoma in High MyopiaNCT05964634 · 2023-08-01
UNKNOWNProviding Financial Incentives to Improve Adherence to Referral Eye Care VisitsNCT04328207 · 2020-11-18
COMPLETEDVillage-Integrated Eye Worker Trial II - PilotNCT03278587 · 2018-05-31
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
UNKNOWN1
WITHDRAWN1
Phase mix
NA3
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.